

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.50860999 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 7.50860999 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.17505404 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 7.17505404 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 7.01107127 |
| 6 | indole-containing compound catabolic process (GO:0042436) | 6.60671389 |
| 7 | indolalkylamine catabolic process (GO:0046218) | 6.60671389 |
| 8 | tryptophan catabolic process (GO:0006569) | 6.60671389 |
| 9 | kynurenine metabolic process (GO:0070189) | 6.32693440 |
| 10 | glyoxylate metabolic process (GO:0046487) | 6.16455526 |
| 11 | tryptophan metabolic process (GO:0006568) | 6.15621482 |
| 12 | * bile acid biosynthetic process (GO:0006699) | 6.08859717 |
| 13 | complement activation, alternative pathway (GO:0006957) | 6.01977779 |
| 14 | regulation of protein activation cascade (GO:2000257) | 5.94279254 |
| 15 | regulation of complement activation (GO:0030449) | 5.66976127 |
| 16 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.65159055 |
| 17 | urea metabolic process (GO:0019627) | 5.59835715 |
| 18 | urea cycle (GO:0000050) | 5.59835715 |
| 19 | cysteine metabolic process (GO:0006534) | 5.59751259 |
| 20 | negative regulation of fibrinolysis (GO:0051918) | 5.38300792 |
| 21 | alpha-linolenic acid metabolic process (GO:0036109) | 5.37737525 |
| 22 | sulfur amino acid catabolic process (GO:0000098) | 5.36745186 |
| 23 | protein carboxylation (GO:0018214) | 5.31294859 |
| 24 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.31294859 |
| 25 | regulation of fibrinolysis (GO:0051917) | 5.29871307 |
| 26 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 5.24500788 |
| 27 | serine family amino acid catabolic process (GO:0009071) | 5.19836594 |
| 28 | nitrogen cycle metabolic process (GO:0071941) | 5.15243981 |
| 29 | aromatic amino acid family metabolic process (GO:0009072) | 5.06757918 |
| 30 | high-density lipoprotein particle remodeling (GO:0034375) | 5.00951492 |
| 31 | * bile acid metabolic process (GO:0008206) | 5.00154070 |
| 32 | homocysteine metabolic process (GO:0050667) | 4.96646031 |
| 33 | lysine metabolic process (GO:0006553) | 4.93907103 |
| 34 | lysine catabolic process (GO:0006554) | 4.93907103 |
| 35 | regulation of T-helper 1 cell differentiation (GO:0045625) | 4.87766504 |
| 36 | coenzyme catabolic process (GO:0009109) | 4.81023516 |
| 37 | alpha-amino acid catabolic process (GO:1901606) | 4.71345198 |
| 38 | cytolysis (GO:0019835) | 4.67235445 |
| 39 | indolalkylamine metabolic process (GO:0006586) | 4.64506284 |
| 40 | amino-acid betaine metabolic process (GO:0006577) | 4.61247681 |
| 41 | regulation of triglyceride catabolic process (GO:0010896) | 4.60009606 |
| 42 | tyrosine metabolic process (GO:0006570) | 4.59969934 |
| 43 | amine catabolic process (GO:0009310) | 4.56613926 |
| 44 | cellular biogenic amine catabolic process (GO:0042402) | 4.56613926 |
| 45 | glycine metabolic process (GO:0006544) | 4.48691845 |
| 46 | regulation of vitamin D biosynthetic process (GO:0060556) | 4.46774389 |
| 47 | reverse cholesterol transport (GO:0043691) | 4.44685953 |
| 48 | triglyceride homeostasis (GO:0070328) | 4.39015555 |
| 49 | acylglycerol homeostasis (GO:0055090) | 4.39015555 |
| 50 | protein-lipid complex remodeling (GO:0034368) | 4.37812845 |
| 51 | macromolecular complex remodeling (GO:0034367) | 4.37812845 |
| 52 | plasma lipoprotein particle remodeling (GO:0034369) | 4.37812845 |
| 53 | serine family amino acid metabolic process (GO:0009069) | 4.37778452 |
| 54 | cellular amino acid catabolic process (GO:0009063) | 4.36949264 |
| 55 | cellular glucuronidation (GO:0052695) | 4.36193584 |
| 56 | bile acid and bile salt transport (GO:0015721) | 4.33427049 |
| 57 | glutamate metabolic process (GO:0006536) | 4.32610756 |
| 58 | cellular ketone body metabolic process (GO:0046950) | 4.30660722 |
| 59 | ethanol oxidation (GO:0006069) | 4.28179913 |
| 60 | cellular modified amino acid catabolic process (GO:0042219) | 4.27106304 |
| 61 | cellular response to type I interferon (GO:0071357) | 4.26310147 |
| 62 | type I interferon signaling pathway (GO:0060337) | 4.26310147 |
| 63 | complement activation, classical pathway (GO:0006958) | 4.23684282 |
| 64 | imidazole-containing compound metabolic process (GO:0052803) | 4.22709478 |
| 65 | regulation of cholesterol esterification (GO:0010872) | 4.20784934 |
| 66 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.18962428 |
| 67 | response to type I interferon (GO:0034340) | 4.17797646 |
| 68 | benzene-containing compound metabolic process (GO:0042537) | 4.14027960 |
| 69 | regulation of interferon-alpha production (GO:0032647) | 4.11909348 |
| 70 | serine family amino acid biosynthetic process (GO:0009070) | 4.11888102 |
| 71 | regulation of chronic inflammatory response (GO:0002676) | 4.10797998 |
| 72 | complement activation (GO:0006956) | 4.08059391 |
| 73 | regulation of cytokine secretion involved in immune response (GO:0002739) | 4.06290072 |
| 74 | negative regulation of sterol transport (GO:0032372) | 4.04091750 |
| 75 | negative regulation of cholesterol transport (GO:0032375) | 4.04091750 |
| 76 | phospholipid efflux (GO:0033700) | 3.98371489 |
| 77 | arginine metabolic process (GO:0006525) | 3.93671335 |
| 78 | aldehyde catabolic process (GO:0046185) | 3.93450621 |
| 79 | acetyl-CoA metabolic process (GO:0006084) | 3.93119848 |
| 80 | fibrinolysis (GO:0042730) | 3.92525761 |
| 81 | protein activation cascade (GO:0072376) | 3.91655045 |
| 82 | plasma lipoprotein particle clearance (GO:0034381) | 3.90661335 |
| 83 | urate metabolic process (GO:0046415) | 3.90219948 |
| 84 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.90068244 |
| 85 | glucuronate metabolic process (GO:0019585) | 3.89407196 |
| 86 | uronic acid metabolic process (GO:0006063) | 3.89407196 |
| 87 | cofactor catabolic process (GO:0051187) | 3.84111858 |
| 88 | regulation of immunoglobulin secretion (GO:0051023) | 3.80950304 |
| 89 | regulation of fever generation (GO:0031620) | 3.80316222 |
| 90 | regulation of bile acid biosynthetic process (GO:0070857) | 3.80195031 |
| 91 | cholesterol efflux (GO:0033344) | 3.79512305 |
| 92 | adhesion of symbiont to host cell (GO:0044650) | 3.78572245 |
| 93 | virion attachment to host cell (GO:0019062) | 3.78572245 |
| 94 | regulation of vitamin metabolic process (GO:0030656) | 3.77823523 |
| 95 | carboxylic acid catabolic process (GO:0046395) | 3.77648453 |
| 96 | organic acid catabolic process (GO:0016054) | 3.77648453 |
| 97 | drug transmembrane transport (GO:0006855) | 3.77168891 |
| 98 | low-density lipoprotein particle remodeling (GO:0034374) | 3.76597206 |
| 99 | blood coagulation, intrinsic pathway (GO:0007597) | 3.73459633 |
| 100 | ketone body metabolic process (GO:1902224) | 3.72147178 |
| 101 | short-chain fatty acid metabolic process (GO:0046459) | 3.70071962 |
| 102 | regulation of cholesterol homeostasis (GO:2000188) | 3.69366843 |
| 103 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 3.69022708 |
| 104 | aspartate family amino acid catabolic process (GO:0009068) | 3.65444345 |
| 105 | drug catabolic process (GO:0042737) | 3.62198778 |
| 106 | NAD biosynthetic process (GO:0009435) | 3.57915707 |
| 107 | pyridine nucleotide biosynthetic process (GO:0019363) | 3.55185256 |
| 108 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.55185256 |
| 109 | cholesterol homeostasis (GO:0042632) | 3.54690468 |
| 110 | plasma lipoprotein particle assembly (GO:0034377) | 3.54612968 |
| 111 | phospholipid homeostasis (GO:0055091) | 3.54249109 |
| 112 | negative regulation of protein activation cascade (GO:2000258) | 3.53796015 |
| 113 | exogenous drug catabolic process (GO:0042738) | 3.53510442 |
| 114 | heme transport (GO:0015886) | 3.51425527 |
| 115 | sterol homeostasis (GO:0055092) | 3.49547165 |
| 116 | adhesion of symbiont to host (GO:0044406) | 3.48037236 |
| 117 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.46317785 |
| 118 | NIK/NF-kappaB signaling (GO:0038061) | 3.43955476 |
| 119 | opsonization (GO:0008228) | 3.43944204 |
| 120 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 3.36112311 |
| 121 | positive regulation of interferon-alpha production (GO:0032727) | 3.35957720 |
| 122 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 3.33302495 |
| 123 | response to protozoan (GO:0001562) | 3.32849236 |
| 124 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 3.31905824 |
| 125 | positive regulation of heat generation (GO:0031652) | 3.30841676 |
| 126 | T-helper 1 type immune response (GO:0042088) | 3.27579690 |
| 127 | germinal center formation (GO:0002467) | 3.26030945 |
| 128 | negative regulation of interleukin-12 production (GO:0032695) | 3.23858532 |
| 129 | myeloid dendritic cell differentiation (GO:0043011) | 3.21868315 |
| 130 | regulation of heterotypic cell-cell adhesion (GO:0034114) | 3.20562457 |
| 131 | regulation of chemokine biosynthetic process (GO:0045073) | 3.19318024 |
| 132 | regulation of nitric oxide biosynthetic process (GO:0045428) | 3.14916201 |
| 133 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.14748059 |
| 134 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.12015016 |
| 135 | defense response to protozoan (GO:0042832) | 3.09850634 |
| 136 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 3.08844015 |
| 137 | omega-hydroxylase P450 pathway (GO:0097267) | 3.02110369 |
| 138 | positive regulation of nitric oxide biosynthetic process (GO:0045429) | 3.01296002 |
| 139 | mature B cell differentiation involved in immune response (GO:0002313) | 3.01049836 |
| 140 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.99922596 |
| 141 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.97525088 |
| 142 | regulation of mononuclear cell migration (GO:0071675) | 2.96658082 |
| 143 | macrophage activation involved in immune response (GO:0002281) | 2.93787208 |
| 144 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 2.93609011 |
| 145 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.91524899 |
| 146 | positive regulation of tyrosine phosphorylation of Stat1 protein (GO:0042511) | 2.90747908 |
| 147 | response to peptidoglycan (GO:0032494) | 2.87462533 |
| 148 | fat-soluble vitamin biosynthetic process (GO:0042362) | 2.86217935 |
| 149 | positive regulation of type 2 immune response (GO:0002830) | 2.86176406 |
| 150 | regulation of T-helper cell differentiation (GO:0045622) | 2.81882150 |
| 151 | immunoglobulin mediated immune response (GO:0016064) | 2.81271523 |
| 152 | regulation of heat generation (GO:0031650) | 2.79313871 |
| 153 | activation of MAPKKK activity (GO:0000185) | 2.78733047 |
| 154 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.77834668 |
| 155 | regulation of interferon-gamma biosynthetic process (GO:0045072) | 2.76577247 |
| 156 | T cell lineage commitment (GO:0002360) | 2.76247017 |
| 157 | cellular response to interferon-alpha (GO:0035457) | 2.74383677 |
| 158 | interleukin-6-mediated signaling pathway (GO:0070102) | 2.71045425 |
| 159 | negative regulation of viral genome replication (GO:0045071) | 2.69779799 |
| 160 | regulation of macrophage chemotaxis (GO:0010758) | 2.69109340 |
| 161 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.66211314 |
| 162 | bone resorption (GO:0045453) | 2.64756850 |
| 163 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.63852948 |
| 164 | myeloid dendritic cell activation (GO:0001773) | 2.63613495 |
| 165 | dendritic cell differentiation (GO:0097028) | 2.62768728 |
| 166 | polyketide metabolic process (GO:0030638) | 2.61125453 |
| 167 | doxorubicin metabolic process (GO:0044598) | 2.61125453 |
| 168 | daunorubicin metabolic process (GO:0044597) | 2.61125453 |
| 169 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.60435376 |
| 170 | positive regulation of T-helper cell differentiation (GO:0045624) | 2.59772876 |
| 171 | cellular response to exogenous dsRNA (GO:0071360) | 2.58653351 |
| 172 | cellular response to lipopolysaccharide (GO:0071222) | 2.54512188 |
| 173 | epoxygenase P450 pathway (GO:0019373) | 2.54179685 |
| 174 | regulation of interleukin-12 production (GO:0032655) | 2.53976852 |
| 175 | positive regulation of humoral immune response (GO:0002922) | 2.53764761 |
| 176 | positive regulation of interferon-beta production (GO:0032728) | 2.53601479 |
| 177 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 2.52856767 |
| 178 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.51256444 |
| 179 | regulation of tyrosine phosphorylation of Stat1 protein (GO:0042510) | 2.49165728 |
| 180 | acute-phase response (GO:0006953) | 2.48102312 |
| 181 | positive regulation of interleukin-12 production (GO:0032735) | 2.46624894 |
| 182 | cellular response to interferon-gamma (GO:0071346) | 2.46427427 |
| 183 | positive regulation of acute inflammatory response (GO:0002675) | 2.46368034 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.20515923 |
| 2 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 7.13067706 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.04652860 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.35492567 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.21668810 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.77108622 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.51356054 |
| 8 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 4.03430379 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.83718850 |
| 10 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.47358709 |
| 11 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.02028712 |
| 12 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.70890740 |
| 13 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.69137842 |
| 14 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.67315243 |
| 15 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.66292675 |
| 16 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.58580677 |
| 17 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.38269423 |
| 18 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.19333341 |
| 19 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.03419464 |
| 20 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.01662780 |
| 21 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.8463340 |
| 22 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.97675451 |
| 23 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.93204140 |
| 24 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.93118224 |
| 25 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.92026569 |
| 26 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.88775637 |
| 27 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.76476364 |
| 28 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.73831772 |
| 29 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.71719662 |
| 30 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.62826658 |
| 31 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.61577685 |
| 32 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.53812906 |
| 33 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.53066423 |
| 34 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.49767371 |
| 35 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.46357131 |
| 36 | GATA1_22025678_ChIP-Seq_K562_Human | 1.41623498 |
| 37 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.40787597 |
| 38 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.39643427 |
| 39 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.39207369 |
| 40 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.38906581 |
| 41 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.36405147 |
| 42 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.26194941 |
| 43 | TP53_16413492_ChIP-PET_HCT116_Human | 1.22658591 |
| 44 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.21347833 |
| 45 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.19953024 |
| 46 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.19928505 |
| 47 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.19411460 |
| 48 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.17067899 |
| 49 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.12579320 |
| 50 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.09999074 |
| 51 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.09911875 |
| 52 | * TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.08910635 |
| 53 | * SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.07707338 |
| 54 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.07535645 |
| 55 | PU1_27457419_Chip-Seq_LIVER_Mouse | 1.05734443 |
| 56 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.05321480 |
| 57 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.04953403 |
| 58 | GATA1_19941826_ChIP-Seq_K562_Human | 1.04907865 |
| 59 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.04884492 |
| 60 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.02069183 |
| 61 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.00633267 |
| 62 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.00320916 |
| 63 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.00111673 |
| 64 | * CJUN_26792858_Chip-Seq_BT549_Human | 0.99845809 |
| 65 | * EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.99258805 |
| 66 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.96585545 |
| 67 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.96198952 |
| 68 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.96137812 |
| 69 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 0.95524177 |
| 70 | * E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.95508099 |
| 71 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.95382520 |
| 72 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.94083680 |
| 73 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.94034197 |
| 74 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.93712821 |
| 75 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.92729608 |
| 76 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.92188764 |
| 77 | KLF4_18555785_Chip-Seq_ESCs_Mouse | 0.90907944 |
| 78 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.90893284 |
| 79 | * SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.90819067 |
| 80 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.90561845 |
| 81 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.89953817 |
| 82 | * NMYC_18555785_Chip-Seq_ESCs_Mouse | 0.89835916 |
| 83 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.89390395 |
| 84 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.89168497 |
| 85 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.88467083 |
| 86 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.88294341 |
| 87 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.87690558 |
| 88 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.86621806 |
| 89 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.86470804 |
| 90 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.85498523 |
| 91 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.85474906 |
| 92 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.84243840 |
| 93 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.84077904 |
| 94 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.83066713 |
| 95 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.82463173 |
| 96 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.82373307 |
| 97 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.82128560 |
| 98 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.81582976 |
| 99 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.81547694 |
| 100 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.80787215 |
| 101 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 0.80768952 |
| 102 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.79926858 |
| 103 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.79926858 |
| 104 | * P53_22387025_ChIP-Seq_ESCs_Mouse | 0.79848805 |
| 105 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.79430708 |
| 106 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.79216030 |
| 107 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.78878257 |
| 108 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.78505917 |
| 109 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.78397666 |
| 110 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.77737369 |
| 111 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.74419219 |
| 112 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.73284847 |
| 113 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.71571797 |
| 114 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.70655755 |
| 115 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.70602023 |
| 116 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.70028231 |
| 117 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.69508234 |
| 118 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.69167280 |
| 119 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.68294323 |
| 120 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.68246594 |
| 121 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.65582741 |
| 122 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.63211249 |
| 123 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.63177279 |
| 124 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.60262647 |
| 125 | AR_20517297_ChIP-Seq_VCAP_Human | 0.59008058 |
| 126 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.57693608 |
| 127 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.57134961 |
| 128 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.56426283 |
| 129 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.56381980 |
| 130 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.54497223 |
| 131 | CBP_21632823_ChIP-Seq_H3396_Human | 0.54187124 |
| 132 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.53996910 |
| 133 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.53849994 |
| 134 | * MYC_19915707_ChIP-ChIP_AK7_Human | 0.53382153 |
| 135 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.53364095 |
| 136 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.52673168 |
| 137 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.50643812 |
| 138 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.50113260 |
| 139 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.49905265 |
| 140 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.49711251 |
| 141 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.49517273 |
| 142 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.49473336 |
| 143 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.49099031 |
| 144 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.48981102 |
| 145 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.48755044 |
| 146 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.48536260 |
| 147 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.46975659 |
| 148 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.46698720 |
| 149 | * STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.46556807 |
| 150 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.45703890 |
| 151 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.45417765 |
| 152 | * TAF2_19829295_ChIP-Seq_ESCs_Human | 0.43690003 |
| 153 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.43352238 |
| 154 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.42288904 |
| 155 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.42037540 |
| 156 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.41288301 |
| 157 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.41276602 |
| 158 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.41136599 |
| 159 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.41047360 |
| 160 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.40869263 |
| 161 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.39615932 |
| 162 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.38847134 |
| 163 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.38170072 |
| 164 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.37896354 |
| 165 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.37789838 |
| 166 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.37254457 |
| 167 | NCOR_22424771_ChIP-Seq_293T_Human | 0.36240023 |
| 168 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.36124864 |
| 169 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.35885109 |
| 170 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.35817609 |
| 171 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.35295173 |
| 172 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.35142955 |
| 173 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.34743844 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.29074563 |
| 2 | MP0005360_urolithiasis | 7.77056631 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.50491920 |
| 4 | MP0005365_abnormal_bile_salt | 6.17008881 |
| 5 | MP0003303_peritoneal_inflammation | 4.92672739 |
| 6 | MP0008875_abnormal_xenobiotic_pharmacok | 4.73340851 |
| 7 | MP0003806_abnormal_nucleotide_metabolis | 4.40747602 |
| 8 | MP0003252_abnormal_bile_duct | 4.09428902 |
| 9 | MP0010329_abnormal_lipoprotein_level | 3.45100388 |
| 10 | MP0003300_gastrointestinal_ulcer | 3.08279404 |
| 11 | MP0005332_abnormal_amino_acid | 2.92046333 |
| 12 | MP0009840_abnormal_foam_cell | 2.90766571 |
| 13 | MP0002148_abnormal_hypersensitivity_rea | 2.89843697 |
| 14 | MP0005083_abnormal_biliary_tract | 2.86065760 |
| 15 | MP0003195_calcinosis | 2.82409872 |
| 16 | MP0001666_abnormal_nutrient_absorption | 2.61042339 |
| 17 | MP0009785_altered_susceptibility_to | 2.56457199 |
| 18 | MP0004510_myositis | 2.54495521 |
| 19 | MP0001835_abnormal_antigen_presentation | 2.50670116 |
| 20 | MP0005387_immune_system_phenotype | 2.39127580 |
| 21 | MP0001790_abnormal_immune_system | 2.39127580 |
| 22 | MP0002138_abnormal_hepatobiliary_system | 2.20991739 |
| 23 | MP0003436_decreased_susceptibility_to | 2.20250254 |
| 24 | MP0006054_spinal_hemorrhage | 2.17501385 |
| 25 | MP0003191_abnormal_cellular_cholesterol | 2.16692874 |
| 26 | MP0004019_abnormal_vitamin_homeostasis | 2.16006224 |
| 27 | MP0008438_abnormal_cutaneous_collagen | 2.15448061 |
| 28 | MP0005397_hematopoietic_system_phenotyp | 2.10253699 |
| 29 | MP0001545_abnormal_hematopoietic_system | 2.10253699 |
| 30 | MP0000609_abnormal_liver_physiology | 2.07625928 |
| 31 | * MP0002118_abnormal_lipid_homeostasis | 2.01221137 |
| 32 | MP0003868_abnormal_feces_composition | 2.01140177 |
| 33 | MP0008004_abnormal_stomach_pH | 1.99792008 |
| 34 | MP0005275_abnormal_skin_tensile | 1.98270071 |
| 35 | MP0005000_abnormal_immune_tolerance | 1.95590592 |
| 36 | MP0005025_abnormal_response_to | 1.88576603 |
| 37 | MP0005319_abnormal_enzyme/_coenzyme | 1.84675433 |
| 38 | MP0002419_abnormal_innate_immunity | 1.81248056 |
| 39 | MP0002332_abnormal_exercise_endurance | 1.81226328 |
| 40 | MP0004947_skin_inflammation | 1.79312320 |
| 41 | MP0003453_abnormal_keratinocyte_physiol | 1.74445096 |
| 42 | MP0001800_abnormal_humoral_immune | 1.67351862 |
| 43 | MP0001764_abnormal_homeostasis | 1.67273102 |
| 44 | MP0005671_abnormal_response_to | 1.67075000 |
| 45 | MP0001542_abnormal_bone_strength | 1.66964514 |
| 46 | MP0000685_abnormal_immune_system | 1.64892232 |
| 47 | MP0000465_gastrointestinal_hemorrhage | 1.63985764 |
| 48 | MP0005023_abnormal_wound_healing | 1.61210984 |
| 49 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.57705575 |
| 50 | MP0001533_abnormal_skeleton_physiology | 1.56483465 |
| 51 | MP0002452_abnormal_antigen_presenting | 1.55102003 |
| 52 | MP0009697_abnormal_copulation | 1.53642772 |
| 53 | MP0002723_abnormal_immune_serum | 1.50111571 |
| 54 | MP0003183_abnormal_peptide_metabolism | 1.45932790 |
| 55 | MP0000343_altered_response_to | 1.44161163 |
| 56 | MP0003011_delayed_dark_adaptation | 1.34690950 |
| 57 | MP0003091_abnormal_cell_migration | 1.34277792 |
| 58 | MP0009643_abnormal_urine_homeostasis | 1.30736309 |
| 59 | MP0000920_abnormal_myelination | 1.26446057 |
| 60 | MP0003186_abnormal_redox_activity | 1.25131445 |
| 61 | MP0001845_abnormal_inflammatory_respons | 1.23518622 |
| 62 | MP0010352_gastrointestinal_tract_polyps | 1.22513437 |
| 63 | MP0003705_abnormal_hypodermis_morpholog | 1.21120174 |
| 64 | MP0005167_abnormal_blood-brain_barrier | 1.17298026 |
| 65 | MP0010155_abnormal_intestine_physiology | 1.13829093 |
| 66 | MP0002998_abnormal_bone_remodeling | 1.13369335 |
| 67 | MP0000598_abnormal_liver_morphology | 1.12320907 |
| 68 | MP0003656_abnormal_erythrocyte_physiolo | 1.10571412 |
| 69 | MP0001819_abnormal_immune_cell | 1.06544139 |
| 70 | MP0009764_decreased_sensitivity_to | 1.06487132 |
| 71 | MP0005451_abnormal_body_composition | 1.06036876 |
| 72 | MP0002420_abnormal_adaptive_immunity | 1.05530436 |
| 73 | MP0002254_reproductive_system_inflammat | 1.04841092 |
| 74 | MP0002405_respiratory_system_inflammati | 1.03272033 |
| 75 | MP0005636_abnormal_mineral_homeostasis | 1.02225664 |
| 76 | MP0000604_amyloidosis | 1.01223170 |
| 77 | MP0010368_abnormal_lymphatic_system | 1.00095973 |
| 78 | MP0005503_abnormal_tendon_morphology | 1.00090911 |
| 79 | MP0005165_increased_susceptibility_to | 0.98737434 |
| 80 | MP0005171_absent_coat_pigmentation | 0.98272413 |
| 81 | MP0005164_abnormal_response_to | 0.97389962 |
| 82 | MP0002877_abnormal_melanocyte_morpholog | 0.96366464 |
| 83 | MP0009763_increased_sensitivity_to | 0.96046588 |
| 84 | MP0002876_abnormal_thyroid_physiology | 0.95170955 |
| 85 | * MP0005647_abnormal_sex_gland | 0.93534931 |
| 86 | MP0005310_abnormal_salivary_gland | 0.92375732 |
| 87 | MP0003448_altered_tumor_morphology | 0.88270805 |
| 88 | MP0008469_abnormal_protein_level | 0.87454567 |
| 89 | MP0005084_abnormal_gallbladder_morpholo | 0.87406425 |
| 90 | MP0009384_cardiac_valve_regurgitation | 0.87326684 |
| 91 | MP0000372_irregular_coat_pigmentation | 0.86528602 |
| 92 | MP0009278_abnormal_bone_marrow | 0.86230501 |
| 93 | MP0005670_abnormal_white_adipose | 0.85646245 |
| 94 | MP0009642_abnormal_blood_homeostasis | 0.84376150 |
| 95 | MP0003950_abnormal_plasma_membrane | 0.83935935 |
| 96 | MP0005220_abnormal_exocrine_pancreas | 0.83583108 |
| 97 | MP0005257_abnormal_intraocular_pressure | 0.83410360 |
| 98 | MP0001501_abnormal_sleep_pattern | 0.82267173 |
| 99 | MP0003279_aneurysm | 0.81332303 |
| 100 | MP0006036_abnormal_mitochondrial_physio | 0.80335248 |
| 101 | MP0005390_skeleton_phenotype | 0.80158731 |
| 102 | MP0005408_hypopigmentation | 0.78798610 |
| 103 | MP0005376_homeostasis/metabolism_phenot | 0.77737763 |
| 104 | MP0003690_abnormal_glial_cell | 0.77287608 |
| 105 | MP0005535_abnormal_body_temperature | 0.77119004 |
| 106 | MP0001851_eye_inflammation | 0.76920652 |
| 107 | MP0005197_abnormal_uvea_morphology | 0.76504969 |
| 108 | MP0000716_abnormal_immune_system | 0.76289714 |
| 109 | MP0003646_muscle_fatigue | 0.75937206 |
| 110 | MP0004381_abnormal_hair_follicle | 0.73647490 |
| 111 | MP0002078_abnormal_glucose_homeostasis | 0.72968031 |
| 112 | MP0009765_abnormal_xenobiotic_induced | 0.72671652 |
| 113 | MP0004130_abnormal_muscle_cell | 0.72036969 |
| 114 | MP0003045_fibrosis | 0.71971024 |
| 115 | MP0003329_amyloid_beta_deposits | 0.67332829 |
| 116 | MP0002933_joint_inflammation | 0.64006252 |
| 117 | MP0005266_abnormal_metabolism | 0.63116232 |
| 118 | MP0002971_abnormal_brown_adipose | 0.62968975 |
| 119 | MP0005334_abnormal_fat_pad | 0.62896290 |
| 120 | MP0002928_abnormal_bile_duct | 0.60276728 |
| 121 | MP0001756_abnormal_urination | 0.60222907 |
| 122 | MP0001661_extended_life_span | 0.59921232 |
| 123 | MP0006035_abnormal_mitochondrial_morpho | 0.59156508 |
| 124 | MP0000639_abnormal_adrenal_gland | 0.55721104 |
| 125 | MP0009379_abnormal_foot_pigmentation | 0.55493872 |
| 126 | MP0000579_abnormal_nail_morphology | 0.53276232 |
| 127 | MP0005166_decreased_susceptibility_to | 0.52774245 |
| 128 | MP0009053_abnormal_anal_canal | 0.52352177 |
| 129 | MP0002136_abnormal_kidney_physiology | 0.49508708 |
| 130 | MP0003075_altered_response_to | 0.48974652 |
| 131 | MP0005395_other_phenotype | 0.46157457 |
| 132 | MP0003638_abnormal_response/metabolism_ | 0.44878672 |
| 133 | MP0005448_abnormal_energy_balance | 0.44582087 |
| 134 | MP0002796_impaired_skin_barrier | 0.44409747 |
| 135 | MP0004043_abnormal_pH_regulation | 0.43298318 |
| 136 | MP0003724_increased_susceptibility_to | 0.43115087 |
| 137 | MP0008874_decreased_physiological_sensi | 0.42067664 |
| 138 | MP0002822_catalepsy | 0.41828665 |
| 139 | MP0003718_maternal_effect | 0.41253676 |
| 140 | MP0005666_abnormal_adipose_tissue | 0.39962384 |
| 141 | MP0003953_abnormal_hormone_level | 0.39845627 |
| 142 | MP0000230_abnormal_systemic_arterial | 0.37399739 |
| 143 | MP0004782_abnormal_surfactant_physiolog | 0.37128856 |
| 144 | MP0002837_dystrophic_cardiac_calcinosis | 0.36671254 |
| 145 | MP0008873_increased_physiological_sensi | 0.35441437 |
| 146 | MP0005464_abnormal_platelet_physiology | 0.34059347 |
| 147 | MP0009672_abnormal_birth_weight | 0.33585968 |
| 148 | MP0001765_abnormal_ion_homeostasis | 0.33052383 |
| 149 | MP0005075_abnormal_melanosome_morpholog | 0.32448559 |
| 150 | MP0005058_abnormal_lysosome_morphology | 0.30828645 |
| 151 | MP0008872_abnormal_physiological_respon | 0.30311779 |
| 152 | MP0005595_abnormal_vascular_smooth | 0.30097338 |
| 153 | MP0002168_other_aberrant_phenotype | 0.29533578 |
| 154 | MP0005248_abnormal_Harderian_gland | 0.29050593 |
| 155 | MP0001853_heart_inflammation | 0.28960160 |
| 156 | MP0001881_abnormal_mammary_gland | 0.28597635 |
| 157 | MP0009115_abnormal_fat_cell | 0.26868129 |
| 158 | MP0004264_abnormal_extraembryonic_tissu | 0.24921139 |
| 159 | MP0000427_abnormal_hair_cycle | 0.24387387 |
| 160 | MP0002970_abnormal_white_adipose | 0.24307529 |
| 161 | MP0002060_abnormal_skin_morphology | 0.24267203 |
| 162 | MP0006082_CNS_inflammation | 0.24035719 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.19667649 |
| 2 | Deep venous thrombosis (HP:0002625) | 7.18962111 |
| 3 | * Intrahepatic cholestasis (HP:0001406) | 7.06790903 |
| 4 | Complement deficiency (HP:0004431) | 6.66287002 |
| 5 | Prolonged partial thromboplastin time (HP:0003645) | 6.51612820 |
| 6 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.45918496 |
| 7 | Xanthomatosis (HP:0000991) | 6.20864507 |
| 8 | Hypobetalipoproteinemia (HP:0003563) | 6.02033241 |
| 9 | Abnormality of glycolipid metabolism (HP:0010969) | 5.33548190 |
| 10 | Abnormality of liposaccharide metabolism (HP:0010968) | 5.33548190 |
| 11 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 5.33548190 |
| 12 | Hyperlipoproteinemia (HP:0010980) | 5.24930171 |
| 13 | Abnormality of complement system (HP:0005339) | 4.83555190 |
| 14 | Hyperglycinemia (HP:0002154) | 4.71072952 |
| 15 | Joint hemorrhage (HP:0005261) | 4.66650475 |
| 16 | Hyperammonemia (HP:0001987) | 4.63290899 |
| 17 | Hypolipoproteinemia (HP:0010981) | 4.56437730 |
| 18 | Epidermoid cyst (HP:0200040) | 4.48671097 |
| 19 | Abnormality of the common coagulation pathway (HP:0010990) | 4.45176720 |
| 20 | Ketosis (HP:0001946) | 4.36611241 |
| 21 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.22925471 |
| 22 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.18676011 |
| 23 | Hyperglycinuria (HP:0003108) | 4.15764183 |
| 24 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.12765489 |
| 25 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.12270650 |
| 26 | Abnormality of glycine metabolism (HP:0010895) | 4.12270650 |
| 27 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.07831042 |
| 28 | Hypoalphalipoproteinemia (HP:0003233) | 4.00331952 |
| 29 | Abnormality of methionine metabolism (HP:0010901) | 3.99797826 |
| 30 | * Fat malabsorption (HP:0002630) | 3.95858227 |
| 31 | Abnormality of the intrinsic pathway (HP:0010989) | 3.88602436 |
| 32 | Retrobulbar optic neuritis (HP:0100654) | 3.83368865 |
| 33 | Optic neuritis (HP:0100653) | 3.83368865 |
| 34 | Conjugated hyperbilirubinemia (HP:0002908) | 3.74839394 |
| 35 | Orchitis (HP:0100796) | 3.71884105 |
| 36 | Hypoglycemic coma (HP:0001325) | 3.70438472 |
| 37 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.63734932 |
| 38 | Loss of speech (HP:0002371) | 3.47818868 |
| 39 | Gastrointestinal stroma tumor (HP:0100723) | 3.40867012 |
| 40 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.33625625 |
| 41 | Purpura (HP:0000979) | 3.32723611 |
| 42 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.30143081 |
| 43 | Petechiae (HP:0000967) | 3.29507757 |
| 44 | Dysostosis multiplex (HP:0000943) | 3.28940766 |
| 45 | Ketoacidosis (HP:0001993) | 3.24417625 |
| 46 | Delayed CNS myelination (HP:0002188) | 3.23947946 |
| 47 | Hypercholesterolemia (HP:0003124) | 3.23525287 |
| 48 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.22046281 |
| 49 | Systemic lupus erythematosus (HP:0002725) | 3.20010025 |
| 50 | Abnormality of serum amino acid levels (HP:0003112) | 3.18044513 |
| 51 | Hyperbilirubinemia (HP:0002904) | 3.16042062 |
| 52 | Keratoconjunctivitis sicca (HP:0001097) | 3.13347295 |
| 53 | Abnormality of nucleobase metabolism (HP:0010932) | 3.10441868 |
| 54 | Spontaneous abortion (HP:0005268) | 3.05525282 |
| 55 | Hypochromic microcytic anemia (HP:0004840) | 3.05132973 |
| 56 | Myocardial infarction (HP:0001658) | 3.01687075 |
| 57 | Gangrene (HP:0100758) | 2.98339431 |
| 58 | Hepatocellular carcinoma (HP:0001402) | 2.96404169 |
| 59 | Gout (HP:0001997) | 2.95833629 |
| 60 | Nephritis (HP:0000123) | 2.90911214 |
| 61 | Keratoconjunctivitis (HP:0001096) | 2.88972975 |
| 62 | Autoimmune thrombocytopenia (HP:0001973) | 2.88068747 |
| 63 | Vacuolated lymphocytes (HP:0001922) | 2.87466211 |
| 64 | Myositis (HP:0100614) | 2.87154352 |
| 65 | Abnormality of purine metabolism (HP:0004352) | 2.83795336 |
| 66 | Skin nodule (HP:0200036) | 2.81266897 |
| 67 | Metabolic acidosis (HP:0001942) | 2.79736467 |
| 68 | Recurrent bronchitis (HP:0002837) | 2.77612388 |
| 69 | Interstitial pulmonary disease (HP:0006530) | 2.75447862 |
| 70 | * Steatorrhea (HP:0002570) | 2.72271807 |
| 71 | Joint swelling (HP:0001386) | 2.71867998 |
| 72 | Lethargy (HP:0001254) | 2.66202888 |
| 73 | IgA deficiency (HP:0002720) | 2.65683323 |
| 74 | Vasculitis (HP:0002633) | 2.61115672 |
| 75 | Vascular calcification (HP:0004934) | 2.59392267 |
| 76 | Dicarboxylic aciduria (HP:0003215) | 2.58311691 |
| 77 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.58311691 |
| 78 | Abnormality of macrophages (HP:0004311) | 2.56209287 |
| 79 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.55515543 |
| 80 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.55515543 |
| 81 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.55515543 |
| 82 | Eczematoid dermatitis (HP:0000976) | 2.51477265 |
| 83 | Spastic diplegia (HP:0001264) | 2.49545220 |
| 84 | Parakeratosis (HP:0001036) | 2.49007548 |
| 85 | Sensorimotor neuropathy (HP:0007141) | 2.48335028 |
| 86 | Increased serum ferritin (HP:0003281) | 2.48309895 |
| 87 | Increased IgE level (HP:0003212) | 2.45213006 |
| 88 | Disinhibition (HP:0000734) | 2.43407160 |
| 89 | Autoimmune hemolytic anemia (HP:0001890) | 2.41932962 |
| 90 | Mucopolysacchariduria (HP:0008155) | 2.40530449 |
| 91 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.40530449 |
| 92 | Mitral stenosis (HP:0001718) | 2.39899010 |
| 93 | Hypergammaglobulinemia (HP:0010702) | 2.39561125 |
| 94 | Mediastinal lymphadenopathy (HP:0100721) | 2.39424715 |
| 95 | Hypoglycemic seizures (HP:0002173) | 2.38861306 |
| 96 | Cerebral edema (HP:0002181) | 2.37920986 |
| 97 | Irritability (HP:0000737) | 2.37823836 |
| 98 | Acanthocytosis (HP:0001927) | 2.37774846 |
| 99 | Abnormal gallbladder morphology (HP:0012437) | 2.37150057 |
| 100 | Basal ganglia calcification (HP:0002135) | 2.34083734 |
| 101 | Vertebral compression fractures (HP:0002953) | 2.33504537 |
| 102 | Cholelithiasis (HP:0001081) | 2.33147619 |
| 103 | Increased IgM level (HP:0003496) | 2.32860812 |
| 104 | Cardiovascular calcification (HP:0011915) | 2.32155321 |
| 105 | Enlarged kidneys (HP:0000105) | 2.29526701 |
| 106 | Abnormal gallbladder physiology (HP:0012438) | 2.29154678 |
| 107 | Cholecystitis (HP:0001082) | 2.29154678 |
| 108 | Erythema (HP:0010783) | 2.27476016 |
| 109 | Emphysema (HP:0002097) | 2.27345692 |
| 110 | Malnutrition (HP:0004395) | 2.22312988 |
| 111 | Neurofibrillary tangles (HP:0002185) | 2.21997873 |
| 112 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.21557724 |
| 113 | Hematochezia (HP:0002573) | 2.20979251 |
| 114 | Pancreatitis (HP:0001733) | 2.19638904 |
| 115 | Amyloidosis (HP:0011034) | 2.16186961 |
| 116 | Thoracolumbar scoliosis (HP:0002944) | 2.15847188 |
| 117 | Glomerulonephritis (HP:0000099) | 2.15370235 |
| 118 | Generalized aminoaciduria (HP:0002909) | 2.14437755 |
| 119 | Hypoplasia of the iris (HP:0007676) | 2.13357697 |
| 120 | Vomiting (HP:0002013) | 2.12648711 |
| 121 | Pulmonary infiltrates (HP:0002113) | 2.11413864 |
| 122 | Osteolytic defects of the hand bones (HP:0009699) | 2.10905993 |
| 123 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.10905993 |
| 124 | Recurrent sinusitis (HP:0011108) | 2.09964171 |
| 125 | Late onset (HP:0003584) | 2.08998957 |
| 126 | Opisthotonus (HP:0002179) | 2.08035029 |
| 127 | Rickets (HP:0002748) | 2.06551392 |
| 128 | Prolonged neonatal jaundice (HP:0006579) | 2.06279898 |
| 129 | Gingival bleeding (HP:0000225) | 2.05690601 |
| 130 | * Neonatal onset (HP:0003623) | 2.05653820 |
| 131 | Esophageal varix (HP:0002040) | 2.05616829 |
| 132 | Thrombophlebitis (HP:0004418) | 2.04519226 |
| 133 | Erythroderma (HP:0001019) | 2.03204851 |
| 134 | Recurrent bacterial skin infections (HP:0005406) | 2.02857405 |
| 135 | Increased cerebral lipofuscin (HP:0011813) | 2.02002680 |
| 136 | Brushfield spots (HP:0001088) | 2.01641337 |
| 137 | Abnormality of the gallbladder (HP:0005264) | 2.01429706 |
| 138 | Recurrent pneumonia (HP:0006532) | 1.97668792 |
| 139 | Status epilepticus (HP:0002133) | 1.97114208 |
| 140 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.94971810 |
| 141 | Arthralgia (HP:0002829) | 1.94885534 |
| 142 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.94106785 |
| 143 | Abnormality of the basal ganglia (HP:0002134) | 1.93675451 |
| 144 | Menorrhagia (HP:0000132) | 1.93395858 |
| 145 | Abnormality of the periventricular white matter (HP:0002518) | 1.92687297 |
| 146 | Alkalosis (HP:0001948) | 1.92094042 |
| 147 | Progressive neurologic deterioration (HP:0002344) | 1.90435839 |
| 148 | Abnormality of the pleura (HP:0002103) | 1.90305469 |
| 149 | Hemorrhage of the eye (HP:0011885) | 1.89872496 |
| 150 | Hyperuricemia (HP:0002149) | 1.88743803 |
| 151 | Increased purine levels (HP:0004368) | 1.88743803 |
| 152 | Abnormality of the pericardium (HP:0001697) | 1.87674425 |
| 153 | Spondylolisthesis (HP:0003302) | 1.87062837 |
| 154 | Pulmonary embolism (HP:0002204) | 1.85046117 |
| 155 | Onycholysis (HP:0001806) | 1.84852682 |
| 156 | Hypophosphatemic rickets (HP:0004912) | 1.84330924 |
| 157 | Dry hair (HP:0011359) | 1.83611111 |
| 158 | Abnormal cartilage morphology (HP:0002763) | 1.83590255 |
| 159 | Hydroxyprolinuria (HP:0003080) | 1.81960303 |
| 160 | Abnormality of proline metabolism (HP:0010907) | 1.81960303 |
| 161 | Recurrent lower respiratory tract infections (HP:0002783) | 1.81944386 |
| 162 | Confusion (HP:0001289) | 1.81934707 |
| 163 | Proximal tubulopathy (HP:0000114) | 1.81820831 |
| 164 | B lymphocytopenia (HP:0010976) | 1.81168390 |
| 165 | Stomatitis (HP:0010280) | 1.79888245 |
| 166 | Renal cortical cysts (HP:0000803) | 1.79716302 |
| 167 | Cellulitis (HP:0100658) | 1.78104490 |
| 168 | Abnormality of vitamin metabolism (HP:0100508) | 1.77709226 |
| 169 | Albinism (HP:0001022) | 1.76681306 |
| 170 | Arterial thrombosis (HP:0004420) | 1.76216501 |
| 171 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.75302825 |
| 172 | Recurrent viral infections (HP:0004429) | 1.74153131 |
| 173 | Abnormality of B cell number (HP:0010975) | 1.73569980 |
| 174 | Abnormality of iron homeostasis (HP:0011031) | 1.73158677 |
| 175 | Back pain (HP:0003418) | 1.72185527 |
| 176 | Mutism (HP:0002300) | 1.72044333 |
| 177 | Polyneuropathy (HP:0001271) | 1.70354611 |
| 178 | Hemoptysis (HP:0002105) | 1.70023805 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 7.06727452 |
| 2 | ERN1 | 4.83404199 |
| 3 | FGFR4 | 4.48978160 |
| 4 | SIK1 | 4.06611656 |
| 5 | ERBB4 | 3.97551750 |
| 6 | DDR2 | 3.81236253 |
| 7 | PIM2 | 3.36356721 |
| 8 | TAOK3 | 3.06952331 |
| 9 | INSRR | 3.04476742 |
| 10 | MATK | 2.62011302 |
| 11 | GRK7 | 2.40762949 |
| 12 | MAP2K4 | 2.39000552 |
| 13 | BMPR2 | 2.38261182 |
| 14 | MAPK11 | 2.25952347 |
| 15 | NME2 | 2.22663325 |
| 16 | KIT | 2.22455897 |
| 17 | IKBKB | 2.16354714 |
| 18 | MST1R | 1.99244715 |
| 19 | LATS1 | 1.88203621 |
| 20 | DAPK3 | 1.85528273 |
| 21 | MOS | 1.81215421 |
| 22 | TRIB3 | 1.78891815 |
| 23 | PIK3CG | 1.66389619 |
| 24 | PRPF4B | 1.64279822 |
| 25 | JAK3 | 1.59735555 |
| 26 | NEK1 | 1.54483110 |
| 27 | ABL2 | 1.50461742 |
| 28 | TYK2 | 1.46830827 |
| 29 | CHUK | 1.42590613 |
| 30 | PDGFRA | 1.41424897 |
| 31 | BLK | 1.38063072 |
| 32 | ADRBK2 | 1.37891948 |
| 33 | IRAK4 | 1.34152859 |
| 34 | NEK9 | 1.33837562 |
| 35 | MAP3K7 | 1.30974746 |
| 36 | PTK6 | 1.30932737 |
| 37 | DAPK2 | 1.29394572 |
| 38 | FLT3 | 1.26325980 |
| 39 | CDC42BPA | 1.26299019 |
| 40 | FRK | 1.26255394 |
| 41 | EPHA4 | 1.26061333 |
| 42 | FGFR2 | 1.25814621 |
| 43 | JAK2 | 1.23114334 |
| 44 | PINK1 | 1.22681614 |
| 45 | ERBB2 | 1.22210597 |
| 46 | PKN2 | 1.18730000 |
| 47 | PIM1 | 1.18293633 |
| 48 | TESK1 | 1.18169052 |
| 49 | MAPKAPK5 | 1.12106466 |
| 50 | GRK6 | 1.11694364 |
| 51 | MAP4K1 | 1.10912512 |
| 52 | STK38L | 1.10335101 |
| 53 | PRKAA2 | 1.07043952 |
| 54 | TAOK1 | 1.01426158 |
| 55 | MAPK15 | 0.99333545 |
| 56 | MAPK12 | 0.98651567 |
| 57 | JAK1 | 0.97761926 |
| 58 | MAPK4 | 0.95776215 |
| 59 | PRKCZ | 0.94701378 |
| 60 | KDR | 0.92031224 |
| 61 | TXK | 0.91675414 |
| 62 | CAMK2G | 0.91535769 |
| 63 | RIPK4 | 0.87981676 |
| 64 | ARAF | 0.85433118 |
| 65 | LYN | 0.85084021 |
| 66 | SYK | 0.84075896 |
| 67 | MAP3K14 | 0.83621380 |
| 68 | MET | 0.82638817 |
| 69 | TIE1 | 0.81445933 |
| 70 | EPHA3 | 0.81139970 |
| 71 | MAPK7 | 0.80390155 |
| 72 | SGK3 | 0.80230124 |
| 73 | IRAK3 | 0.78972688 |
| 74 | TBK1 | 0.78942508 |
| 75 | PBK | 0.77430545 |
| 76 | CDK6 | 0.76168638 |
| 77 | MAP3K10 | 0.76139661 |
| 78 | PKN1 | 0.75501018 |
| 79 | MAP2K3 | 0.74069478 |
| 80 | PRKACG | 0.72982325 |
| 81 | SGK2 | 0.72641493 |
| 82 | EPHB1 | 0.72118769 |
| 83 | PRKAA1 | 0.69632397 |
| 84 | CSNK1A1L | 0.65980094 |
| 85 | PRKCG | 0.65938706 |
| 86 | GSK3A | 0.65220810 |
| 87 | SCYL2 | 0.64396652 |
| 88 | MAP3K3 | 0.63376373 |
| 89 | CLK1 | 0.63082252 |
| 90 | SGK494 | 0.60950391 |
| 91 | SGK223 | 0.60950391 |
| 92 | MAP3K13 | 0.59888048 |
| 93 | PDPK1 | 0.57671971 |
| 94 | FGR | 0.56421823 |
| 95 | FGFR3 | 0.55988998 |
| 96 | CSNK1G2 | 0.55581939 |
| 97 | MAP2K6 | 0.55243374 |
| 98 | PTK2 | 0.54451188 |
| 99 | DYRK3 | 0.54214024 |
| 100 | VRK1 | 0.53438854 |
| 101 | EIF2AK3 | 0.53353803 |
| 102 | LATS2 | 0.50297360 |
| 103 | ABL1 | 0.50263890 |
| 104 | MAP3K11 | 0.49974338 |
| 105 | IGF1R | 0.49785206 |
| 106 | MARK3 | 0.49440274 |
| 107 | CDK9 | 0.48783705 |
| 108 | HIPK2 | 0.48534283 |
| 109 | MAP3K6 | 0.48079370 |
| 110 | PRKCQ | 0.47883548 |
| 111 | DYRK1B | 0.47451763 |
| 112 | GRK5 | 0.46978078 |
| 113 | RPS6KA5 | 0.46594273 |
| 114 | CSNK1G3 | 0.46310054 |
| 115 | INSR | 0.46086123 |
| 116 | CAMK1D | 0.45361629 |
| 117 | MAP2K1 | 0.45073306 |
| 118 | TGFBR1 | 0.44908300 |
| 119 | TAF1 | 0.44407360 |
| 120 | TAOK2 | 0.43605803 |
| 121 | PRKCD | 0.43526963 |
| 122 | EIF2AK2 | 0.42076397 |
| 123 | MAP3K5 | 0.40372987 |
| 124 | LCK | 0.40315874 |
| 125 | WNK3 | 0.40273211 |
| 126 | TGFBR2 | 0.39635726 |
| 127 | CSF1R | 0.39305014 |
| 128 | EGFR | 0.38201274 |
| 129 | STK24 | 0.38090357 |
| 130 | WNK4 | 0.37808059 |
| 131 | GRK1 | 0.37270420 |
| 132 | STK10 | 0.36715599 |
| 133 | CSK | 0.36443404 |
| 134 | DAPK1 | 0.36343034 |
| 135 | CSNK1G1 | 0.35809470 |
| 136 | PAK3 | 0.35665391 |
| 137 | PRKCH | 0.34924831 |
| 138 | RIPK1 | 0.34379372 |
| 139 | AKT3 | 0.34328147 |
| 140 | PRKCA | 0.33706400 |
| 141 | IRAK1 | 0.33544190 |
| 142 | RET | 0.32898907 |
| 143 | MAP3K1 | 0.32338527 |
| 144 | CAMK4 | 0.31030146 |
| 145 | PDK1 | 0.30324498 |
| 146 | PDGFRB | 0.30214518 |
| 147 | PDK3 | 0.29812245 |
| 148 | PDK4 | 0.29812245 |
| 149 | IKBKE | 0.29395568 |
| 150 | CDK4 | 0.29374115 |
| 151 | TRIM28 | 0.29089982 |
| 152 | MAPK3 | 0.28728472 |
| 153 | STK38 | 0.25247837 |
| 154 | CCNB1 | 0.24932651 |
| 155 | IRAK2 | 0.23949962 |
| 156 | MAPKAPK2 | 0.23490669 |
| 157 | FER | 0.23311860 |
| 158 | MTOR | 0.23300397 |
| 159 | MAP3K2 | 0.22902006 |
| 160 | ROCK2 | 0.22458324 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.67664166 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.53458631 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.37300952 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.19606523 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.03496142 |
| 6 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.89758499 |
| 7 | Asthma_Homo sapiens_hsa05310 | 2.83343844 |
| 8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.76952377 |
| 9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.72473015 |
| 10 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.58602706 |
| 11 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.56777082 |
| 12 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.54276600 |
| 13 | Allograft rejection_Homo sapiens_hsa05330 | 2.52827328 |
| 14 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.47332225 |
| 15 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.47204031 |
| 16 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.26510292 |
| 17 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.23103888 |
| 18 | Peroxisome_Homo sapiens_hsa04146 | 2.19493598 |
| 19 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.15516228 |
| 20 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.10004823 |
| 21 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.01202956 |
| 22 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.98130490 |
| 23 | Malaria_Homo sapiens_hsa05144 | 1.97755587 |
| 24 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.97333994 |
| 25 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.90710687 |
| 26 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.90463825 |
| 27 | Other glycan degradation_Homo sapiens_hsa00511 | 1.90147999 |
| 28 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.86445428 |
| 29 | Pertussis_Homo sapiens_hsa05133 | 1.83032965 |
| 30 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.82084218 |
| 31 | Histidine metabolism_Homo sapiens_hsa00340 | 1.81403095 |
| 32 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.79152690 |
| 33 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.79002723 |
| 34 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.75883257 |
| 35 | * Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.74749783 |
| 36 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.73616899 |
| 37 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.68021253 |
| 38 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.67649488 |
| 39 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.66821305 |
| 40 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.66418545 |
| 41 | Retinol metabolism_Homo sapiens_hsa00830 | 1.65901316 |
| 42 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.64013057 |
| 43 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.63954197 |
| 44 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.63096218 |
| 45 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.61544536 |
| 46 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.60073736 |
| 47 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.57007408 |
| 48 | Leishmaniasis_Homo sapiens_hsa05140 | 1.55352589 |
| 49 | Bile secretion_Homo sapiens_hsa04976 | 1.54954898 |
| 50 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.53750242 |
| 51 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.52611885 |
| 52 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.45940192 |
| 53 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.43874896 |
| 54 | Lysosome_Homo sapiens_hsa04142 | 1.41667879 |
| 55 | Influenza A_Homo sapiens_hsa05164 | 1.40531511 |
| 56 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.38500383 |
| 57 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.37418521 |
| 58 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.30471846 |
| 59 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.30299700 |
| 60 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.27413929 |
| 61 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.23114701 |
| 62 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.20608515 |
| 63 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.19212388 |
| 64 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.19009683 |
| 65 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.15219075 |
| 66 | ABC transporters_Homo sapiens_hsa02010 | 1.15008651 |
| 67 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.14963505 |
| 68 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.13640733 |
| 69 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.13468959 |
| 70 | Carbon metabolism_Homo sapiens_hsa01200 | 1.13218226 |
| 71 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.11243802 |
| 72 | Tuberculosis_Homo sapiens_hsa05152 | 1.10715072 |
| 73 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.06883447 |
| 74 | Measles_Homo sapiens_hsa05162 | 1.06282569 |
| 75 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.05769260 |
| 76 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.04117899 |
| 77 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.03881232 |
| 78 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.03418660 |
| 79 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.02175767 |
| 80 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.01691459 |
| 81 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.99351272 |
| 82 | Sulfur relay system_Homo sapiens_hsa04122 | 0.96050916 |
| 83 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.94956039 |
| 84 | Viral myocarditis_Homo sapiens_hsa05416 | 0.94909248 |
| 85 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.93978903 |
| 86 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.92694523 |
| 87 | Legionellosis_Homo sapiens_hsa05134 | 0.92322754 |
| 88 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.91079249 |
| 89 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.90284288 |
| 90 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.87766605 |
| 91 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.84750123 |
| 92 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.82905416 |
| 93 | Lysine degradation_Homo sapiens_hsa00310 | 0.80631792 |
| 94 | Prion diseases_Homo sapiens_hsa05020 | 0.73780353 |
| 95 | Salmonella infection_Homo sapiens_hsa05132 | 0.73703484 |
| 96 | Hepatitis B_Homo sapiens_hsa05161 | 0.70344287 |
| 97 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.70074521 |
| 98 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.69580469 |
| 99 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.67002471 |
| 100 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.66571091 |
| 101 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.65745931 |
| 102 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.61547317 |
| 103 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.61141932 |
| 104 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.58355165 |
| 105 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.54962374 |
| 106 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.52225080 |
| 107 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.50187569 |
| 108 | Phagosome_Homo sapiens_hsa04145 | 0.48124323 |
| 109 | Metabolic pathways_Homo sapiens_hsa01100 | 0.47219363 |
| 110 | Apoptosis_Homo sapiens_hsa04210 | 0.46447702 |
| 111 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.44326457 |
| 112 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.38380825 |
| 113 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.35667661 |
| 114 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.34277263 |
| 115 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.29207056 |
| 116 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.29129770 |
| 117 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.28867529 |
| 118 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.26384148 |
| 119 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.26168003 |
| 120 | Shigellosis_Homo sapiens_hsa05131 | 0.24365506 |
| 121 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.23192412 |
| 122 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.22554255 |
| 123 | Insulin resistance_Homo sapiens_hsa04931 | 0.21742161 |
| 124 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.21736644 |
| 125 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.21399167 |
| 126 | Galactose metabolism_Homo sapiens_hsa00052 | 0.21386764 |
| 127 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.18563144 |
| 128 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.15326288 |
| 129 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.13658615 |
| 130 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.13016606 |
| 131 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.11730432 |
| 132 | Mineral absorption_Homo sapiens_hsa04978 | -0.2180995 |
| 133 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.2162120 |
| 134 | Bladder cancer_Homo sapiens_hsa05219 | -0.1994340 |
| 135 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.1785857 |
| 136 | Hepatitis C_Homo sapiens_hsa05160 | -0.1658823 |
| 137 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1592417 |
| 138 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.1590507 |
| 139 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.1580782 |
| 140 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1580503 |
| 141 | Amoebiasis_Homo sapiens_hsa05146 | -0.1541820 |
| 142 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1442245 |
| 143 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1371052 |
| 144 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1223870 |
| 145 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1163503 |
| 146 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1154579 |
| 147 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.1150632 |
| 148 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1099630 |
| 149 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.0877554 |
| 150 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0841924 |
| 151 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0608954 |
| 152 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.0402653 |
| 153 | AMPK signaling pathway_Homo sapiens_hsa04152 | -0.0095855 |

